Therapeutic options for treatment of human papillomavirus-associated cancers - novel immunologic vaccines: ADXS11–001

Survival of patients with advanced, recurrent, or metastatic human papillomavirus (HPV)-associated cancer is suboptimal despite the availability of various treatment modalities. The recently developed bacterial vector Listeria monocytogenes (Lm) activates innate and adaptive immune responses and is...

Descripción completa

Detalles Bibliográficos
Autores principales: Miles, Brett, Safran, Howard P., Monk, Bradley J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512733/
https://www.ncbi.nlm.nih.gov/pubmed/28725449
http://dx.doi.org/10.1186/s40661-017-0047-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512733/
https://www.ncbi.nlm.nih.gov/pubmed/28725449
http://dx.doi.org/10.1186/s40661-017-0047-8

Ejemplares similares